BSG and inflammatory bowel disease: The expression of CD147 is increased in the intestinal mucosa of patients with IBD, and serum CD147, associated with DAI, is higher in inflamed patients than in noninflamed patients, which suggested that CD147 could be a serum biomarker in the IBD progress.